Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway

Neurochemical Research

Volumn 37, Issue 5, 2012, Pages 983-990

  Chen, Tao ^a   Cao, Lei ^b   Dong, Wenpeng ^c   Luo, Peng ^a   Liu, Wenbo ^a   Qu, Yan ^a   Fei, Zhou ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

ERK; Neuroprotective effect; PKC; Traumatic brain injury

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 CHLORO 5 HYDROXYPHENYLGLYCINE; 3 CYANO N (1,3 DIPHENYL 1H PYRAZOL 5 YL)BENZAMIDE; CASPASE 3; CHELERYTHRINE; LACTATE DEHYDROGENASE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR AGONIST; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FEMALE; IN VITRO STUDY; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; BENZAMIDES; BLOTTING, WESTERN; BRAIN INJURIES; CELLS, CULTURED; ENZYME ACTIVATION; EXCITATORY AMINO ACID AGONISTS; FEMALE; GLYCINE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROPROTECTIVE AGENTS; PHENYLACETATES; PHOSPHORYLATION; PREGNANCY; PROTEIN KINASE C; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84862903594     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0691-z     Document Type: Article

References (36)

1. Jordan BD (2007) Genetic influences on outcome following traumatic brain injury. Neurochem Res 32:905-915 (Pubitemid 46481316)
2. Davis AE (2000) Cognitive impairments following traumatic brain injury. Etiologies and interventions. Crit Care Nurs Clin North Am 12:447-456
3. Chen T et al (2011) Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Res Bull 84:163-168
4. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634
5. Fei Z et al (2007) Posttraumatic secondary brain insults exacerbates neuronal injury by altering metabotropic glutamate receptors. BMC Neurosci 8:96
6. Flor PJ et al (2002) Neuroprotective activity of metabotropic glutamate receptor ligands. Adv Exp Med Biol 513:197-223 (Pubitemid 36332408)
7. Kew JN, Kemp JA (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacol Berl 179:4-29 (Pubitemid 40576690)
8. Pin JP, Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26
9. Bruno V et al (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 21:1013-1033 (Pubitemid 32823739)
10. Fei Z et al (2006) Metabotropic glutamate receptor antagonists and agonists: potential neuroprotectors in diffuse brain injury. J Clin Neurosci 13:1023-1027 (Pubitemid 44750674)
11. Nicoletti F et al (1996) Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 19:267-271 (Pubitemid 26000672)
12. D'Antoni S et al (2008) Metabotropic glutamate receptors in glial cells. Neurochem Res 33:2436-2443
13. Morin N et al (2010) Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacology 58:981-986
14. Parmentier-Batteur S et al (2010) Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration. Neuropharmacology. doi:10.1016/j.neuropharm.2010.11.013
15. Redmond L, Kashani AH, Ghosh A (2002) Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription. Neuron 34:999-1010 (Pubitemid 34722288)
16. Faden AI et al (2001) Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma. Exp Neurol 167:435-444 (Pubitemid 32150901)
17. Huang WD, Fei Z, Zhang X (2005) Traumatic injury induced homer-1a gene expression in cultured cortical neurons of rat. Neurosci Lett 389:46-50 (Pubitemid 41219432)
18. O'Leary DM et al (2000) Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol 131:1429-1437
19. Movsesyan VA et al (2001) mGluR5 antagonists 2-methyl-6-(phenylethynyl)- pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 296:41-47 (Pubitemid 32015058)
20. Movsesyan VA, Stoica BA, Faden AI (2004) MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor. J Neurochem 89:1528-1536 (Pubitemid 38802674)
21. Liu F et al (2005) The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides. J Neurochem 95:1363-1372 (Pubitemid 41779261)
22. Doherty AJ et al (1997) (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 36:265-267 (Pubitemid 27149516)
23. You Z et al (2008) Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 28:1564-1573
24. Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405
25. Huang T et al (2009) Traumatic injury activates MAP kinases in astrocytes: mechanisms of hypothermia and hyperthermia. J Neurotrauma 26:1535-1545
26. Chen T et al (2011) Neuroprotective effect of osthole against oxygen and glucose deprivation in rat cortical neurons: involvement of mitogen-activated protein kinase pathway. Neuroscience 183:203-211
27. Mori T et al (2002) Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J Cereb Blood Flow Metab 22:444-452 (Pubitemid 34273600)
28. Otani N et al (2002) Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus. J Cereb Blood Flow Metab 22:327-334 (Pubitemid 34203060)
29. Xia Z et al (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331
30. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237 (Pubitemid 27238875)
31. De Blasi A et al (2001) Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 22:114-120 (Pubitemid 32181842)
32. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496
33. Sugano T et al (2006) Enhancement of insulin-induced PI3 K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells. J Neurochem 98:20-33 (Pubitemid 43882929)
34. Bhave G, Gereau RWt (2004) Posttranslational mechanisms of peripheral sensitization. J Neurobiol 61:88-106 (Pubitemid 39287772)
35. Gold MS, Flake NM (2005) Inflammation-mediated hyperexcitability of sensory neurons. Neurosignals 14:147-157 (Pubitemid 41417103)
36. Bright R, Mochly-Rosen D (2005) The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 36:2781-2790